2021 Q1 Form 10-Q Financial Statement

#000156459021024182 Filed on May 05, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $93.05M $35.01M
YoY Change 165.81% -21.94%
Cost Of Revenue $58.20M $24.22M
YoY Change 140.27% -19.42%
Gross Profit $34.86M $10.79M
YoY Change 223.18% -27.06%
Gross Profit Margin 37.46% 30.81%
Selling, General & Admin $18.58M $13.37M
YoY Change 38.97% 15.97%
% of Gross Profit 53.31% 123.98%
Research & Development $3.993M $2.427M
YoY Change 64.52% 66.69%
% of Gross Profit 11.46% 22.5%
Depreciation & Amortization $739.0K $1.033M
YoY Change -28.46% -0.67%
% of Gross Profit 2.12% 9.58%
Operating Expenses $22.58M $15.80M
YoY Change 42.9% 21.65%
Operating Profit $12.28M -$5.013M
YoY Change -344.96% -378.35%
Interest Expense $97.00K $169.0K
YoY Change -42.6% -30.74%
% of Operating Profit 0.79%
Other Income/Expense, Net -$579.0K -$197.0K
YoY Change 193.91% -111.85%
Pretax Income $11.60M -$5.379M
YoY Change -315.73% -267.1%
Income Tax $2.800M -$1.800M
% Of Pretax Income 24.13%
Net Earnings $8.838M -$3.555M
YoY Change -348.61% -216.37%
Net Earnings / Revenue 9.5% -10.16%
Basic Earnings Per Share $0.57 -$0.25
Diluted Earnings Per Share $0.49 -$0.25
COMMON SHARES
Basic Shares Outstanding 15.55M 14.50M
Diluted Shares Outstanding 18.20M 14.50M

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $63.00M $8.700M
YoY Change 624.14% -14.71%
Cash & Equivalents $62.97M $8.733M
Short-Term Investments
Other Short-Term Assets $14.70M $5.200M
YoY Change 182.69% 8.33%
Inventory $59.14M $39.30M
Prepaid Expenses
Receivables $32.37M $12.40M
Other Receivables $0.00 $0.00
Total Short-Term Assets $169.2M $65.60M
YoY Change 157.87% -8.74%
LONG-TERM ASSETS
Property, Plant & Equipment $7.089M $4.002M
YoY Change 77.14% -23.26%
Goodwill $10.69M $8.515M
YoY Change 25.5%
Intangibles $6.760M $5.740M
YoY Change 17.77% 475.73%
Long-Term Investments
YoY Change
Other Assets $8.900M $10.30M
YoY Change -13.59% 1044.44%
Total Long-Term Assets $38.25M $30.14M
YoY Change 26.92% 200.07%
TOTAL ASSETS
Total Short-Term Assets $169.2M $65.60M
Total Long-Term Assets $38.25M $30.14M
Total Assets $207.4M $95.73M
YoY Change 116.65% 16.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $27.76M $11.50M
YoY Change 141.34% -12.01%
Accrued Expenses $34.90M $19.40M
YoY Change 79.9% 16.87%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $300.0K
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $71.77M $32.59M
YoY Change 120.23% 9.9%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $5.079M $3.021M
YoY Change 68.12% -35.41%
Total Long-Term Liabilities $5.079M $3.021M
YoY Change 68.12% -35.41%
TOTAL LIABILITIES
Total Short-Term Liabilities $71.77M $32.59M
Total Long-Term Liabilities $5.079M $3.021M
Total Liabilities $80.28M $35.75M
YoY Change 124.56% 3.58%
SHAREHOLDERS EQUITY
Retained Earnings -$65.94M -$117.1M
YoY Change -43.68% -8.83%
Common Stock $16.00K $15.00K
YoY Change 6.67% 7.14%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $127.1M $59.98M
YoY Change
Total Liabilities & Shareholders Equity $207.4M $95.73M
YoY Change 116.65% 16.86%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income $8.838M -$3.555M
YoY Change -348.61% -216.37%
Depreciation, Depletion And Amortization $739.0K $1.033M
YoY Change -28.46% -0.67%
Cash From Operating Activities $21.09M $17.53M
YoY Change 20.32% -57.21%
INVESTING ACTIVITIES
Capital Expenditures $2.280M $890.0K
YoY Change 156.18% 59.78%
Acquisitions $2.500M
YoY Change
Other Investing Activities -$2.500M
YoY Change
Cash From Investing Activities -$4.780M -$890.0K
YoY Change 437.08% 59.78%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 696.0K -15.38M
YoY Change -104.52% -58.94%
NET CHANGE
Cash From Operating Activities 21.09M 17.53M
Cash From Investing Activities -4.780M -890.0K
Cash From Financing Activities 696.0K -15.38M
Net Change In Cash 16.28M 484.0K
YoY Change 3264.46% -84.28%
FREE CASH FLOW
Cash From Operating Activities $21.09M $17.53M
Capital Expenditures $2.280M $890.0K
Free Cash Flow $18.81M $16.64M
YoY Change 13.05% -58.83%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11604000
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
35007000
CY2021Q1 us-gaap Cost Of Revenue
CostOfRevenue
58198000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
93053000
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q1 us-gaap Cost Of Revenue
CostOfRevenue
24222000
CY2021Q1 us-gaap Gross Profit
GrossProfit
34855000
CY2020Q1 us-gaap Gross Profit
GrossProfit
10785000
CY2021Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
11545000
CY2020Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
7648000
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3993000
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2427000
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7037000
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5723000
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
22575000
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
15798000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
12280000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5013000
CY2021Q1 us-gaap Interest Expense
InterestExpense
97000
CY2020Q1 us-gaap Interest Expense
InterestExpense
169000
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-579000
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-197000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5379000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2766000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1824000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
8838000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-3555000
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.57
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.25
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.49
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.25
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15551000
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14495000
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18076000
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14495000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
8838000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-3555000
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-711000
CY2020Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-819000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-819000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
8127000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4374000
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
62965000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
46681000
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
32370000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
43867000
CY2021Q1 us-gaap Inventory Net
InventoryNet
59136000
CY2020Q4 us-gaap Inventory Net
InventoryNet
71301000
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
14685000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8127000
CY2021Q1 us-gaap Assets Current
AssetsCurrent
169156000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
169976000
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7089000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6575000
CY2021Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
7334000
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
6946000
CY2021Q1 us-gaap Goodwill
Goodwill
10686000
CY2020Q4 us-gaap Goodwill
Goodwill
8178000
CY2021Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
6760000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5138000
CY2021Q1 us-gaap Other Assets
OtherAssets
6380000
CY2020Q4 us-gaap Other Assets
OtherAssets
6640000
CY2021Q1 us-gaap Assets
Assets
207405000
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
27761000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
42529000
CY2021Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
44011000
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
36122000
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
71772000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
78651000
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5079000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5257000
CY2021Q1 us-gaap Liabilities
Liabilities
80283000
CY2020Q4 us-gaap Liabilities
Liabilities
87054000
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15653644
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15653644
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15475504
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15475504
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
16000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
15000
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
193163000
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
190568000
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-65935000
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-122000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
589000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
127122000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
116399000
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
207405000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
203453000
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
739000
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1033000
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
303000
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
222000
CY2021Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
47000
CY2020Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
47000
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1786000
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
999000
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-388000
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1891000
CY2021Q1 hear Revenue From Contract With Customer Sales Returns Reserve For Sales Returns
RevenueFromContractWithCustomerSalesReturnsReserveForSalesReturns
-678000
CY2020Q1 hear Revenue From Contract With Customer Sales Returns Reserve For Sales Returns
RevenueFromContractWithCustomerSalesReturnsReserveForSalesReturns
2553000
CY2021Q1 us-gaap Inventory Write Down
InventoryWriteDown
57000
CY2020Q1 us-gaap Inventory Write Down
InventoryWriteDown
439000
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-10819000
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-12108000
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-711000
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y5M8D
CY2021Q1 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherLiabilitiesNoncurrent
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y9M10D
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y9M3D
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y8M26D
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.005
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.596
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.011
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.598
CY2021Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y2M12D
CY2021Q1 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherLiabilitiesCurrent
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6568000
CY2021Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
3086000
CY2021Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
5251000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
21087000
CY2020Q4 us-gaap Assets
Assets
203453000
CY2021Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
3432000
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
3146000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-74773000
CY2020Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
21000
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-34681000
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-5981000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-15669000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-11192000
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1091000
CY2020Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-132000
CY2020Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-5483000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
17526000
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2280000
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
890000
CY2021Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
2500000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4780000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-890000
CY2021Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
97032000
CY2020Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
48426000
CY2021Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
97032000
CY2020Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
63780000
CY2021Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
911000
CY2020Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
18000
CY2021Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
215000
CY2020Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
48000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
696000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-15384000
CY2021Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-719000
CY2020Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-768000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
16284000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
484000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8249000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
62965000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8733000
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
64000
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
161000
CY2021Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
5000
CY2020Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
175000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
116399000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
8838000
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-711000
CY2021Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
113000
CY2021Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
215000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
912000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1786000
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
63387000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-3555000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-819000
CY2020Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
1000
CY2020Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
48000
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
18000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
999000
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
59983000
CY2021Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Use of estimates<span style="font-style:normal;">: The preparation of accompanying unaudited consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions about future events. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited consolidated financial statements and reported amounts of revenues and expenses during the reporting period. These estimates may change, as new events occur and additional information is obtained, and will be recognized in the consolidated financial statements in the period in which such changes occur. Future actual results could differ materially from these estimates. </span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The novel coronavirus (“COVID-19”) pandemic has disrupted worldwide economic markets and the extent to which COVID-19 continues to affect the Company’s business, results of operations and financial condition will depend on future developments, which are highly uncertain and difficult to predict. We continue to actively monitor and assess the impact of the pandemic on our business, operations, and financial condition.</p>
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
889000
CY2021Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
57965000
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
69939000
CY2021Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1171000
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1362000
CY2021Q1 us-gaap Inventory Net
InventoryNet
59136000
CY2020Q4 us-gaap Inventory Net
InventoryNet
71301000
CY2021Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
28514000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
27795000
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
21425000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
21220000
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7089000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6575000
CY2021Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5741000
CY2021Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
9126000
CY2020Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
5670000
CY2021Q1 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
9001000
CY2020Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
5166000
CY2021Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7709000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7138000
CY2021Q1 hear Accrued Freight Current
AccruedFreightCurrent
2282000
CY2020Q4 hear Accrued Freight Current
AccruedFreightCurrent
3401000
CY2021Q1 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
5332000
CY2020Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
5487000
CY2021Q1 hear Accrued Contingent Consideration
AccruedContingentConsideration
1928000
CY2021Q1 hear Accrued Expenses Current
AccruedExpensesCurrent
8633000
CY2020Q4 hear Accrued Expenses Current
AccruedExpensesCurrent
9260000
CY2021Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
44011000
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
36122000
CY2021Q1 hear Finite Lived Intangible Assets Foreign Currency Gross
FiniteLivedIntangibleAssetsForeignCurrencyGross
804000
CY2021Q1 hear Finite Lived Intangible Assets Foreign Currency Accumulated Amortization
FiniteLivedIntangibleAssetsForeignCurrencyAccumulatedAmortization
757000
CY2021Q1 hear Finite Lived Intangible Assets Foreign Currency Net
FiniteLivedIntangibleAssetsForeignCurrencyNet
47000
CY2021Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
12501000
CY2021Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
6760000
CY2020Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
10540000
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5402000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5138000
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
300000
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
200000
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
988000
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1281000
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1041000
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1008000
CY2021Q1 hear Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
1600000
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6807000
CY2020Q4 us-gaap Goodwill
Goodwill
8178000
CY2021Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
2508000
CY2021Q1 us-gaap Goodwill
Goodwill
10686000
CY2021Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
100000
CY2020Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
200000
CY2021Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
47000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2766000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1824000
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.238
CY2020Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.339
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2800000
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.238
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1800000
CY2021Q1 hear Unrecognized Tax Benefits Inclusive Of Interest And Penalties
UnrecognizedTaxBenefitsInclusiveOfInterestAndPenalties
3900000
CY2021Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
800000
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1786000
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
999000
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
12.04
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2230549
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.09
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
41454353
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2174246
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
8.11
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
40498749
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
501000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
12000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
6000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
88000
CY2021Q1 hear Forfeited Expired Restricted Stock Added Back
ForfeitedExpiredRestrictedStockAddedBack
2000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
409000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2383427
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.85
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
33064942
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
11550
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
27.20
CY2021Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
158544
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
5.75
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
5884
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
855796
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.74
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
16289457
CY2021Q1 hear Sharebased Compensation Arrangement By Sharebased Payment Award Forfeiture Period After Ending Employment
SharebasedCompensationArrangementBySharebasedPaymentAwardForfeiturePeriodAfterEndingEmployment
P90D
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
4200000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
14.89
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
300000
CY2021Q1 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
550000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
8838000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-3555000
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15551000
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14495000
CY2021Q1 hear Incremental Common Shares Attributable To Dilutive Effect Of Restricted Stock Awards
IncrementalCommonSharesAttributableToDilutiveEffectOfRestrictedStockAwards
517000
CY2021Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1458000
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18076000
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14495000
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.57
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.25
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.49
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.25
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3103000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
93053000
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
35007000
CY2020Q2 hear Number Of Shareholders
NumberOfShareholders
8
CY2020Q3 hear Number Of Motions
NumberOfMotions
2
CY2020Q2 hear Number Of Distributors
NumberOfDistributors
2
CY2020Q3 hear Number Of Companies
NumberOfCompanies
2
CY2020Q3 hear Accounts Receivable Outstanding
AccountsReceivableOutstanding
130000
CY2020Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1039000
CY2019Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
743000
CY2021Q1 us-gaap Product Warranty Expense
ProductWarrantyExpense
334000
CY2020Q1 us-gaap Product Warranty Expense
ProductWarrantyExpense
146000
CY2021Q1 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
255000
CY2020Q1 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
177000
CY2021Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1118000
CY2020Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
712000
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4771000
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
840000
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4951000
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
5791000
CY2021Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
300000
CY2021Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
200000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
874000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
846000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
728000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
737000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
708000
CY2021Q1 hear Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
2967000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
6860000
CY2021Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1069000
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
5791000

Files In Submission

Name View Source Status
0001564590-21-024182-index-headers.html Edgar Link pending
0001564590-21-024182-index.html Edgar Link pending
0001564590-21-024182.txt Edgar Link pending
0001564590-21-024182-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gmn2by3vie3j000001.jpg Edgar Link pending
hear-10q_20210331.htm Edgar Link pending
hear-10q_20210331_htm.xml Edgar Link completed
hear-20210331.xsd Edgar Link pending
hear-20210331_cal.xml Edgar Link unprocessable
hear-20210331_def.xml Edgar Link unprocessable
hear-20210331_lab.xml Edgar Link unprocessable
hear-20210331_pre.xml Edgar Link unprocessable
hear-ex311_8.htm Edgar Link pending
hear-ex312_6.htm Edgar Link pending
hear-ex321_7.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending